2019;40:3143 53. 4. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replace- ment with a self-expanding prosthesis. N Engl J Med. 2014;370:1790 8. 5. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aor- tic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477 84. 6. Deeb GM, Reardon MJ, Chetcuti S, et al. 3-Year outcomes in high-risk pa- tients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2565 74. 7. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609 20. 8. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve re- placement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218 25. 9. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replace- ment with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695 705. 10. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve re- placement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706 15. 11. Siontis KC, Killu AM. Silent and non-silent thromboembolic events after ventricular tachycardia ablation: modifiable risk with postprocedure anti- coagulation? J Cardiovasc Electrophysiol. 2019;30:1197 9. 12. Kapadia SR, Leon MB, Makkar RR, et al. 5-Year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2485 91. 13. Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replace- ment using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972 81. 14. Leon MB, Smith CR, Mack M, et al. 